EP 4373496 A1 20240529 - COMPOSITION OR FORMULATION COMPRISING ONE OR MORE 5-ALPHA-REDUCTASE INHIBITORS AND ONE OR MORE BILE ACIDS
Title (en)
COMPOSITION OR FORMULATION COMPRISING ONE OR MORE 5-ALPHA-REDUCTASE INHIBITORS AND ONE OR MORE BILE ACIDS
Title (de)
ZUSAMMENSETZUNG ODER FORMULIERUNG MIT EINEM ODER MEHREREN 5-ALPHA-REDUKTASE-HEMMERN UND EINER ODER MEHREREN GALLENSÄUREN
Title (fr)
COMPOSITION OU FORMULATION COMPRENANT UN OU PLUSIEURS INHIBITEURS DE 5-ALPHA-RÉDUCTASE ET UN OU PLUSIEURS ACIDES BILIAIRES
Publication
Application
Priority
- IT 202100004898 A 20210302
- IB 2022051834 W 20220302
Abstract (en)
[origin: WO2022185228A1] The purpose of the invention is to provide a topical composition for the treatment of androgen-dependent dermatoses characterized by the association of one or more bile acids and one or more inhibitors of the 5 alpha reductase enzyme. A composition or formulation comprising one or more inhibitors of 5 alpha reductase and one or more bile acids is useful for the treatment of pathologies linked to androgenic imbalance (androgenic dermatoses) with the ability to limit the side effects of the inhibitors, of 5 alpha reductase and enhance the cytoprotective effects of bile acids.
IPC 8 full level
A61K 31/575 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 31/05 (2006.01); A61K 31/122 (2006.01); A61K 31/4375 (2006.01); A61K 31/57 (2006.01); A61K 31/58 (2006.01); A61K 45/06 (2006.01); A61P 17/00 (2006.01); A61P 17/08 (2006.01); A61P 17/10 (2006.01); A61P 17/14 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/08 (2013.01); A61K 31/05 (2013.01); A61K 31/122 (2013.01); A61K 31/4375 (2013.01); A61K 31/57 (2013.01); A61K 31/575 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01); A61P 17/00 (2017.12); A61P 17/08 (2017.12); A61P 17/10 (2017.12); A61P 17/14 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 2022185228A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022185228 A1 20220909; EP 4373496 A1 20240529; IT 202100004898 A1 20220902
DOCDB simple family (application)
IB 2022051834 W 20220302; EP 22713729 A 20220302; IT 202100004898 A 20210302